Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News LNG Energy Group Corp. V.LNGE

Alternate Symbol(s):  V.LNGE.W | LNGNF

Energy Oil & Gas E&P
LNG Energy Group Corp is a Canada-based company, which is focused on the acquisition and development of natural gas production and exploration assets in Latin America. The Company’s assets include Sinu-San Jacinto-1(SSJN-1), Valle Inferior del Magdelana-41 (VIM-41), Valle Inferior del Magdalena-42 (VIM-42) and Sinu-San Jacinto 3-1(SSJN 3-1). The Company has a 50% working interest in SSJN-1, VIM... see more

Recent & Breaking News (TSXV:LNGE)

MINDCURE Appoints Dr. John Brownstein, the Chief Innovation Officer at Boston Children's Hospital, as Company Advisor

Canada NewsWire May 19, 2021

MINDCURE Shares Update on Strong Financial Position, Near Term Revenue Drivers and Timeline for iSTRYM's Market Launch, Delivering Mental Wealth

Canada NewsWire April 29, 2021

MINDCURE Announces Partnership with SOMA Breath Inc. to License its Breathwork Program and Develop Custom Breathwork for Psychedelic-Assisted Psychotherapies within iSTRYM

Canada NewsWire April 27, 2021

MINDCURE Announces Experienced Finance Executive Michael Wolfe as CFO and appoints Larissa Chaikowsky to its Board of Directors

Canada NewsWire April 22, 2021

MINDCURE Partners its iSTRYM Technology with LUCID to Discover and Create Proprietary Music Experiences for Use During Psychedelic-Assisted Therapy Sessions

Canada NewsWire April 21, 2021

Industry Leaders Look To Artificial Intelligence To Drive Advancements In Mental Healthcare

Livemoney April 14, 2021

MINDCURE Announces The Addition of Daniel Herrera, A Pharmaceutical Industry Executive With Specific Experience in Medical Psychoactive Segment

Canada NewsWire April 14, 2021

MINDCURE Announces Partnership with Speak Ai to Enhance iSTRYM, the Company's Psychedelic Digital Therapeutics Technology Platform

Canada NewsWire April 13, 2021

MINDCURE Announces Additional Equity Investment in ATMA, The First Government Approved Psychedelic Journey Centers In Canada; MCUR President and CEO, Kelsey Ramsden Named to ATMA Board of Directors

Canada NewsWire April 8, 2021

Emerging Markets Report: The Mushroom Movement

GlobeNewswire April 7, 2021

MINDCURE Files Provisional Patent Application For iSTRYM, its Proprietary AI Digital Therapeutics (DTx) SaaS Platform, Designed To Enhance Effectiveness Of Psychedelic-Assisted Therapies For Practitioners And Patients

Canada NewsWire March 31, 2021

March Psychedelic Capital Investigates Ethical IP and Financial Instruments

Newsfile March 30, 2021

Emerging Markets Report: A Psychedelic Solution to a National Crisis

GlobeNewswire March 23, 2021

Ty Tashiro joins MINDCURE as the Senior Translational and Psychometric Architect for iSTRYM's AI-Driven Psychedelic Digital Therapeutic Technology

Canada NewsWire March 19, 2021

MINDCURE Names Tarik Lebbadi as Chief Operating Officer

Canada NewsWire March 15, 2021

MINDCURE Receives Unconditional Ethics Approval for its Psychedelic Integration Protocol Research Study

Canada NewsWire March 9, 2021

MINDCURE Discovers Potential Opportunity for Ibogaine-Assisted Psychotherapy to Treat Neuropathic Pain and Traumatic Brain Injury

Canada NewsWire March 4, 2021

MINDCURE Announces Manufacturing of Synthetic Ibogaine to be Used in Company's Clinical Research

Canada NewsWire March 3, 2021

Innovators Identify Crucial Advancements to Uncover Medical Breakthroughs From Psychedelics

Livemoney March 2, 2021

MINDCURE Completes Its Initial Strategic Equity Investment in ATMA, Canada's First Commercial Provider of Legal, Psychedelic-Assisted, Therapy Utilizing Psilocybin

Canada NewsWire March 2, 2021